Provided by Tiger Trade Technology Pte. Ltd.

Zimmer Biomet

96.78
-1.6300-1.66%
Post-market: 96.780.00000.00%19:30 EDT
Volume:1.89M
Turnover:183.76M
Market Cap:18.48B
PE:23.49
High:98.41
Open:97.75
Low:96.39
Close:98.41
52wk High:106.88
52wk Low:79.12
Shares:191.00M
Float Shares:190.00M
Volume Ratio:0.86
T/O Rate:0.99%
Dividend:0.96
Dividend Rate:0.99%
EPS(TTM):4.12
EPS(LYR):3.55
ROE:6.41%
ROA:3.88%
PB:1.46
PE(LYR):27.26

Loading ...

Zimmer Biomet Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 16

BUZZ-U.S. STOCKS ON THE MOVE-Tyler Technologies, Autodesk, Illumina

Reuters
·
May 13

Zimmer Biomet Boosts Buyback Guidance by $250 Million

Dow Jones
·
May 12

Zimmer Biomet Raises Fiscal 2026 Share Repurchase Target to $1 Billion

MT Newswires Live
·
May 12

Zimmer Biomet Increases Share Repurchase Expectations -- up to $1 Billion by Year End

THOMSON REUTERS
·
May 12

Zimmer Biomet Holdings Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
May 12

Zimmer Biomet Holdings Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
May 09

Zimmer Biomet Q1 net earnings climb to USD 238.1 million; net sales rise 9.3% to USD 2.09 billion

Reuters
·
May 02

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Phathom Pharmaceuticals (PHAT) and Zimmer Biomet Holdings (ZBH)

TIPRANKS
·
May 01

Stryker misses quarterly estimates on muted demand for medical devices

Reuters
·
May 01

Pro-Dex FY26 Q3 net income rises 20% to $3.9 million; net sales climb 15% to $19.9 million

Reuters
·
May 01

Zimmer Biomet Holdings, Inc : Leerink Partners Cuts Target Price to $90 From $101

THOMSON REUTERS
·
Apr 30

Zimmer Biomet Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Apr 30

Stryker's Fundamentals 'Solidly Intact' Despite Cyber Disruption, RBC Says

MT Newswires Live
·
Apr 30

Zimmer Biomet Supported by Sales Force Improvements, 2026 Upside Potential, RBC Says

MT Newswires Live
·
Apr 30

Zimmer Biomet participates in a conference call with JPMorgan

TIPRANKS
·
Apr 29

These Analysts Slash Their Forecasts On Zimmer Biomet Following Q1 Results

Benzinga Earnings
·
Apr 29

Zimmer Biomet Holdings Is Maintained at Underweight by Barclays

Dow Jones
·
Apr 29

Citigroup Adjusts Price Target on Zimmer Biomet to $95 From $98, Maintains Neutral Rating

MT Newswires Live
·
Apr 29

JPMorgan Adjusts Price Target on Zimmer Biomet Holdings to $95 From $100, Maintains Neutral Rating

MT Newswires Live
·
Apr 29